Prognostic value of liver fibrosis and steatosis biomarkers in type-2 diabetes and dyslipidaemia.
Perazzo H, Munteanu M, Ngo Y, Lebray P, Seurat N, Rutka F, Couteau M, Jacqueminet S, Giral P, Monneret D, Imbert-Bismut F, Ratziu V, Hartemann-Huertier A, Housset C, Poynard T; FLIP Consortium.
Perazzo H, et al. Among authors: poynard t.
Aliment Pharmacol Ther. 2014 Nov;40(9):1081-93. doi: 10.1111/apt.12946. Epub 2014 Sep 3.
Aliment Pharmacol Ther. 2014.
PMID: 25186086